Combating TKI resistance in CML by inhibiting the PI3K/Akt/mTOR pathway in combination with TKIs: a review
Priyanka Singh, Veerandra Kumar, Sonu Gupta, Gudia Kumari, Malkhey Verma
Topics & Concepts
PI3K/AKT/mTOR pathwayProtein kinase BEverolimusCancer researchIdelalisibMedicineNilotinibImatinibPharmacologyMyeloid leukemiaLeukemiaBiologySignal transductionInternal medicineIbrutinibChronic lymphocytic leukemiaCell biologyChronic Myeloid Leukemia TreatmentsQuinazolinone synthesis and applicationsChronic Lymphocytic Leukemia Research